Loxo Oncology develops oncological drugs for well-defined patient groups, whose cancers share common genetic drivers.
View Top Employees from Loxo OncologyWebsite | http://www.loxooncology.com |
Ticker | LOXO |
Revenue | $21 million |
Funding | $68.4 million |
Employees | View employees |
Founded | 2013 |
Address | 281 Tresser Blvd, Fl 9, Stamford, Connecticut 06901, US |
Phone | (203) 653-3880 |
Industry | Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
Web Rank | 3 Million |
Keywords | Loxo Oncology, Filetype:Pdf Loxo305, Loxo 292, Ret Point Mutation, Loxo |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 541711 Companies, NAICS Code 325 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 325414 Companies |
Looking for a particular Loxo Oncology employee's phone or email?
The Loxo Oncology annual revenue was $21 million in 2023.
Loxo Oncology is based in Stamford, Connecticut.
The NAICS codes for Loxo Oncology are [54, 3254, 32, 541, 32541, 541711, 325, 54171, 5417, 325414].
The SIC codes for Loxo Oncology are [28, 283].